The Serological Gastric Biopsy: a Non-Endoscopical Diagnostic Approach in Management of the Dyspeptic Patient Significance for Primary Care Based on a Survey of the Literature

References

• Numans ME, Wit NJ de, Geerdes RHM, Murris JWM, Starmans R, Postema PhJ, et al. Dutch College of General Practitioners Guideline on Dyspepsia. Huisarts Wet 1996;39:565–77.
   Google Scholar
• Kagevi I, Lofstedt S, Persson LG. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989;24:145–5o.
   Google Scholar
• Adang RP, Vismans JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrugger RW. The diagnostic outcome of upper gastrointestinal endoscopy: are referral source and age determining factors? Eur J Gastroenterol Hepatol 1994;6:329–35.
   Web of Science ®Google Scholar
• Bytzer P, Moller-Hansen J, Havelund T, Malchow-Moller A, Schaffalitzky De Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359–63.
   PubMed Web of Science ®Google Scholar
• Hansen JM, Bytzer P, Schaffalitzky De Muckadell OB. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998;33:799–805.
   Google Scholar
• Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans JF, Stockbrugger RW. The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1147 patients. Digestion 1996;57:118–34.
   PubMed Web of Science ®Google Scholar
• Bustamente M, Ferrando MJ, Devesa F, Borghol A. The prediction of the endoscopic diagnosis in the dyspepsia patient: the value of the predominating presenting symptom and the initial clinical presumption. Gastroenterol Hepatol 2000;23:66–70.
   PubMedGoogle Scholar
• Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, et al. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 2001;49:29–34.
   PubMed Web of Science ®Google Scholar
• Lewin-van den Broek NT, Numans ME, Buskens E, Verheij TJ, de Wit NJ, Smout AJ. A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome. Br J Gen Pract 2001 ; 51:612–4.
   PubMed Web of Science ®Google Scholar
• Loffeld RJLF, Stobberingh E, Flendrig JA, Spreeuwel JP van, Arends JW. Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet 1989;1:1182–5.
   Google Scholar
• Werdmuller BFM, Putten ABMM van der, Veenendaal RA, Lamers CBHW, Loffeld RJLF. Can screening for IgG antibodies against Helicobacter pylori be used in clinical practice? Omit endoscopy in seropositive or seronegative patients? Dig Dis Sci 1998;43:2296–300.
   Google Scholar
• Weijnen C, Numans ME, Wit NJ de, Smout AJP, Moons KGM, Verheij TJM, et al. Testing for Helicobacter pylori in patients suspected of peptic ulcer disease in primary care: cross sectional study. Br Med J 2001;323:71–5.
   PubMed Web of Science ®Google Scholar
• Biemond I, Kreuning J, Jansen JB, Lamers CB. Serum pepsinogens in patients with gastric diseases or after gastric surgery. Scand J Gastroenterol 1994;29:238–42.
   PubMed Web of Science ®Google Scholar
• Schlemper R, Werf SDJ van der, Biemond I, Lamers CBHW. Seroepidemiology of gastritis in Japanese and Dutch ulcer and non-ulcer male employees. Eur J Gastroenterol Hepatol 1996:8: 33–9.
   PubMed Web of Science ®Google Scholar
• Oksanen A, Sipponen P, Miettinen A, Sarna S, Rautelin H. Evaluation of blood tests to predict normal gastric mucosa. Scand J Gastroenterol 2000;35:791–5.
   Google Scholar
• Walsh JH, Grossman MI. Gastrin. N Engl J Med 1975;292:132 4 and 1377.
   Google Scholar
• Kreuning J, Samloff IM, Rotter JI, Eriksson AW, editors. Pepsinogens in man. New York: Alan R. Liss; 1985.
   Google Scholar
• Foltmann B. Gastric proteinases: structure, function, evolution and mechanism of action. Essays Biochem 1981;17:52–84.
   PubMed Web of Science ®Google Scholar
• Modlin IM. From Prout to the protonpump. Gastrin. Schnetztor-Verlag GmbH: Konstanz; 1995. p. 59–67.
   Google Scholar
• Lamers CBHW, Tongeren JHM van. De klinische betekenis van de gastrinebepaling in het serum. Ned Tijdschr Geneesk 1975; 51:2024–32.
   Google Scholar
• Lamers CB. Clinical aspects of gastrointestinal hormones. Neth J Med 1978;21:77–82.
   PubMed Web of Science ®Google Scholar
• Ten Kate RW, Tuynman HA, Festen HP, Pals G, Meuwissen SG. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man. Eur J Clin Pharmacol 1988;35 : 173–6.
   Google Scholar
• Peyre S, Di Napoli A, Pelissero A, Sategna-Guidetti C. Diagnostic usefulness of serum group 1 pepsinogen determination. Gastroenterol Clin Biol 1983:7: 793.
   Google Scholar
• Bodger K, Wyatt JI, Heatley RV. Serologic screening before endoscopy : the value of Helicobacte r serology, serum recognition of the CagA and the VacA proteins and serum pepsinogen I. Scand J Gastroenterol 1999;34:856–63.
   Google Scholar
• Feltkamp TEW. Auto-immuungastritis. In: Hermans EH et al., editors. Autoimmuunziekten. Leiden: Stafleu; 1971. p. 85–91.
   Google Scholar
• Biemond I, Jansen JBMJ, Crobach LFSJ, Kreuning J, Lamers CBHW. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem 1989;27:19–25.
   PubMed Web of Science ®Google Scholar
• Biemond I, Kreuning J, Jansen JB, Lamers CB. Diagnostic value of serum pepsinogen C in patients with elevated serum concentrations of pepsinogen A. Gut 1993;34:1315–8.
   PubMed Web of Science ®Google Scholar
• Westerveld BD, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987;59:952–8.
   PubMed Web of Science ®Google Scholar
• Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000;46: 460–3.
   PubMed Web of Science ®Google Scholar
• Kekki M, Samloff IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991;Suppl 186:109–16.
   Google Scholar
• Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24:870–6.
   Google Scholar
• Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173–7.
   Google Scholar
• Correa P. Human gastric carcinogenesis : a multistep and multifactorial process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735–40.
   PubMed Web of Science ®Google Scholar
• Hartog G den, Jansen JB, Schaardenburg DJ, Lamfers EJ, Boomgaard RM van den, Kreuning J, et al. Plasma gastrin responses to bombesin and antral gastrin concentrations in patients with the intestinal type of gastric cancer. Cancer Res 1988;48:2296–8.
   PubMed Web of Science ®Google Scholar
• Warren R, Marshall B. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983:i:1273–5.
   Google Scholar
• Tytgat GNJ. Campylobacter pylori, past, present and future. Campylobacter pylori—Its rise from obscurity. Adis Press Int Ltd; 1989. p. 1–11.
   Google Scholar
• Kuipers EJ, Pals G, Pefla AS, Crusius JBA, Uffelen CWJ van, Westerveld BD, et al. Helicobacter pylori, pepsinogens and gastrin; relation to age and development of atrophic gastritis. Eur J Gastroenterol Hepatol 1996;8:153–6.
   PubMed Web of Science ®Google Scholar
• Calam J, Gibbons A, Healey ZV, Bliss P, Arebi N. How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 1997;113 Suppl: S43–9.
   Google Scholar
• Hunter FM, Correa P, Fontham E, Ruiz B, Sobhan M, Samloff IM. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993;38:2081–6.
   PubMed Web of Science ®Google Scholar
• Varis K, Kekki M, Harkonen M, Sipponen P, SamloffIM. Serum pepsinogen 1 and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991; Suppl 186:117–23.
   Google Scholar
• Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels and serum gastrin levels. Cancer 1987;59:952–8.
   PubMed Web of Science ®Google Scholar
• Modlin IM. From Prout to the proton pump. Chapter: The identification of the proton pump, an optimal therapeutic target. Schnetztor-Verlag GmbH: Konstanz; 1995. p. 77–91.
   Google Scholar
• Biemond I, Crobach LFSJ, Jansen JBMJ, Lamers CBHW. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Eur J Clin Pharm 1989;37:345–9.
   PubMed Web of Science ®Google Scholar
• Lamers CBH. Het Zollinger-Ellison syndroom. Ned Tijdschr Geneesk 1974;24:913–22.
   Google Scholar
• Adang RP, Vismans JFE, Talmon JL, Hasman A, Ambergen AW, Stockbrügger RW. Appropriateness of indications for diagnostic upper gastrointestinal endoscopy: association with relevant endoscopic disease. Gastrointest Endosc 1995;42: 390–7.
   Google Scholar